A Form 4 filed with the SEC on August 3, 2026, reports that Michael H. Carrel, President, CEO, and Director of AtriCure, Inc. ( Nasdaq : ATRC), disposed of a combined 4,700 shares of common stock on July 30, 2026, via two separate gift transactions, each at a price of $0.

Key Highlights

  • Gift to parent: 700 shares of AtriCure common stock were disposed of on July 30, 2026, coded "G" (gift), at $0, with no consideration received, according to the filing.
  • Charitable gift: 4,000 shares were disposed of on the same date, also coded "G," at $0, with no consideration received, as a charitable gift.
  • Direct ownership after transactions: Following both disposals, Carrel directly held 774,434 shares of AtriCure common stock.
  • Indirect holdings: The filing also reports 14,310 shares held by the reporting person's children, 2,950 shares held by a parent, and 1,000 shares held by a sibling, all indirectly; Carrel disclaims beneficial ownership of these except as to his pecuniary interest.
  • Reporting person: Michael H. Carrel serves as President, CEO, and Director of AtriCure, Inc., and filed as one individual reporting person.

AtriCure CEO Carrel Transfers Shares via Gift Transactions on July 30, 2026

According to the Form 4 filed with the SEC and dated August 3, 2026, Michael H. Carrel conducted two gift transactions in AtriCure, Inc. (NASDAQ: ATRC) common stock on July 30, 2026. Both transactions carried transaction code "G," indicating gifts. The filing states that no consideration was received in either case. The first transaction involved 700 shares gifted to Carrel's parent; the second involved 4,000 shares described as a charitable gift.

Following the two disposals, the filing reports that Carrel directly beneficially owned 774,434 shares of AtriCure common stock. In addition, the filing lists indirect holdings: 14,310 shares held by the reporting person's children, 2,950 shares held by the reporting person's parent, and 1,000 shares held by the reporting person's sibling. The filing notes that "the reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein."

The Form 4 was signed by Michael H. Carrel on August 3, 2026. No derivative securities transactions were reported. The filing does not indicate that any transaction was made pursuant to a Rule 10b5-1(c) plan. The company's forward-looking statements, if any, are the company's own and subject to its cautionary language as contained in its filings.

What Was Disclosed

The filing discloses two gift disposals totaling 4,700 shares of AtriCure common stock by CEO Michael H. Carrel on July 30, 2026, one to a parent and one charitable, both at $0, leaving him with 774,434 shares held directly.